Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:2220-2241
Published online before print August 17, 2006, doi: 10.1161/01.STR.0000237236.88823.47
Free Article
This Article
Free upon publication Free Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v38,p1118)
Right arrow All Versions of this Article:
37/9/2220    most recent
01.STR.0000237236.88823.47v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hachinski, V.
Right arrow Articles by Leblanc, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hachinski, V.
Right arrow Articles by Leblanc, G. G.
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Animal models of human disease
Right arrow CT and MRI
Right arrow Behavioral Changes and Stroke
Right arrow Cerebral Lacunes
Right arrow Genetics of Stroke
Right arrow Pathology of Stroke
Right arrowRelated Article

(Stroke. 2006;37:2220.)
© 2006 American Heart Association, Inc.


Original Contributions

National Institute of Neurological Disorders and Stroke–Canadian Stroke Network Vascular Cognitive Impairment Harmonization Standards

Vladimir Hachinski, MD, DSc; Costantino Iadecola, MD; Ron C. Petersen, MD, PhD; Monique M. Breteler, MD, PhD; David L. Nyenhuis, PhD; Sandra E. Black, MD; William J. Powers, MD; Charles DeCarli, MD; Jose G. Merino, MD; Raj N. Kalaria, PhD, FRCP; Harry V. Vinters, MD; David M. Holtzman, MD; Gary A. Rosenberg, MD; Anders Wallin; Martin Dichgans, MD; John R. Marler, MD Gabrielle G. Leblanc, PhD

From the London Health Sciences Centre (V.H.), University Campus, London, Ontario, Canada; the Department of Neurology and Neuroscience (C.I.), Division of Neurobiology, Weill Cornell Medical College, New York, NY; the Department of Neurology (R.C.P.), Mayo Clinic, Rochester, MN; the Department of Epidemiology and Biostatistics (M.M.B.), Erasmus Medical Center, Rotterdam, The Netherlands; the Department of Neurology and Rehabilitation (D.L.N.), University of Illinois at Chicago, Chicago, IL; the Division of Neurology Sunnybrook and Women’s College (S.E.B.), Health Sciences Centre, Toronto, Ontario, Canada; the Department of Neurology (W.J.P., D.M.H.), Washington University, School of Medicine, St. Louis, MO; the Department of Neurology (C.D.), University of California at Davis, Sacramento, CA; the Section on Stroke Diagnostics and Therapeutics (J.G.M.), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD; the Wolfson Centre (Neuropathology), Institute for Ageing and Health (R.N.K.), Newcastle General Hospital, Newcastle upon Tyne, UK; the Department of Pathology and Laboratory Medicine (H.V.V.), Section of Neuropathology, University of California, Los Angeles, UCLA Medical Center, Los Angeles, CA; the Department of Neurology (G.A.R.), University of New Mexico, Albuquerque, NM; the Neurologische Klinik (M.D.), Ludwig-Maximilians-Universität München, Klinikum Grosshadern, München, Germany; and the National Institute of Neurological Disorders and Stroke (J.R.M., G.G.L.), National Institutes of Health, Bethesda, MD.

Correspondence to Gabrielle G. Leblanc, PhD, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 6001 Executive Boulevard, Room 2136, Bethesda, MD 20892. E-mail leblancg{at}ninds.nih.gov

Background and Purpose— One in 3 individuals will experience a stroke, dementia or both. Moreover, twice as many individuals will have cognitive impairment short of dementia as either stroke or dementia. The commonly used stroke scales do not measure cognition, while dementia criteria focus on the late stages of cognitive impairment, and are heavily biased toward the diagnosis of Alzheimer disease. No commonly agreed standards exist for identifying and describing individuals with cognitive impairment, particularly in the early stages, and especially with cognitive impairment related to vascular factors, or vascular cognitive impairment.

Methods— The National Institute for Neurological Disorders and Stroke (NINDS) and the Canadian Stroke Network (CSN) convened researchers in clinical diagnosis, epidemiology, neuropsychology, brain imaging, neuropathology, experimental models, biomarkers, genetics, and clinical trials to recommend minimum, common, clinical and research standards for the description and study of vascular cognitive impairment.

Results— The results of these discussions are reported herein.

Conclusions— The development of common standards represents a first step in a process of use, validation and refinement. Using the same standards will help identify individuals in the early stages of cognitive impairment, will make studies comparable, and by integrating knowledge, will accelerate the pace of progress.


Key Words: Binswangers disease • CADASIL • syndrome • cerebral infarction • cerebrovascular disorders • dementia • genetics • ischemia • lacunar infarction • leukoaraiosis • neuropsychology • stroke • vascular dementia


Related Article:

Welcome Harmonizations
José M. Ferro
Stroke 2006 37: 2197. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
NeurologyHome page
S. M. Gregoire, U. J. Chaudhary, M. M. Brown, T. A. Yousry, C. Kallis, H. R. Jager, and D. J. Werring
The Microbleed Anatomical Rating Scale (MARS): Reliability of a tool to map brain microbleeds
Neurology, November 24, 2009; 73(21): 1759 - 1766.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. I. Geerlings, A. P. A. Appelman, K. L. Vincken, W. P. T. M. Mali, and Yolanda van der Graaf for the SMART Study Group
Association of White Matter Lesions and Lacunar Infarcts With Executive Functioning: The SMART-MR Study
Am. J. Epidemiol., November 1, 2009; 170(9): 1147 - 1155.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. Riegel, D. K. Moser, S. D. Anker, L. J. Appel, S. B. Dunbar, K. L. Grady, M. Z. Gurvitz, E. P. Havranek, C. S. Lee, J. Lindenfeld, et al.
State of the Science: Promoting Self-Care in Persons With Heart Failure: A Scientific Statement From the American Heart Association
Circulation, September 22, 2009; 120(12): 1141 - 1163.
[Full Text] [PDF]


Home page
NeurologyHome page
S. R. Lesage, T. H. Mosley, T. Y. Wong, M. Szklo, D. Knopman, D. J. Catellier, S. R. Cole, R. Klein, J. Coresh, L. H. Coker, et al.
Retinal microvascular abnormalities and cognitive decline: The ARIC 14-year follow-up study
Neurology, September 15, 2009; 73(11): 862 - 868.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
L. Koski, H. Xie, and L. Finch
Measuring Cognition in a Geriatric Outpatient Clinic: Rasch Analysis of the Montreal Cognitive Assessment
J Geriatr Psychiatry Neurol, September 1, 2009; 22(3): 151 - 160.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Melkas, N K J Oksala, H Jokinen, T Pohjasvaara, R Vataja, A Oksala, M Kaste, P J Karhunen, and T Erkinjuntti
Poststroke dementia predicts poor survival in long-term follow-up: influence of prestroke cognitive decline and previous stroke
J. Neurol. Neurosurg. Psychiatry, August 1, 2009; 80(8): 865 - 870.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
C. H Rojas-Fernandez and P. Moorhouse
Current Concepts in Vascular Cognitive Impairment and Pharmacotherapeutic Implications
Ann. Pharmacother., July 1, 2009; 43(7): 1310 - 1323.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
J. Verghese, Cuiling Wang, M. J. Katz, A. Sanders, and R. B. Lipton
Leisure Activities and Risk of Vascular Cognitive Impairment in Older Adults
J Geriatr Psychiatry Neurol, June 1, 2009; 22(2): 110 - 118.
[Abstract] [PDF]


Home page
StrokeHome page
Y. Yamamoto, M. Ihara, C. Tham, R. W.C. Low, J. Y. Slade, T. Moss, A. E. Oakley, T. Polvikoski, and R. N. Kalaria
Neuropathological Correlates of Temporal Pole White Matter Hyperintensities in CADASIL
Stroke, June 1, 2009; 40(6): 2004 - 2011.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
G. M. Savva, S. B. Wharton, P. G. Ince, G. Forster, F. E. Matthews, C. Brayne, and the Medical Research Council Cognitive Function an
Age, Neuropathology, and Dementia
N. Engl. J. Med., May 28, 2009; 360(22): 2302 - 2309.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
G. A. Rosenberg
Inflammation and White Matter Damage in Vascular Cognitive Impairment
Stroke, March 1, 2009; 40(3_suppl_1): S20 - S23.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
E. J. Burton, R. Barber, E. B. Mukaetova-Ladinska, J. Robson, R. H. Perry, E. Jaros, R. N. Kalaria, and J. T. O'Brien
Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis
Brain, January 1, 2009; 132(1): 195 - 203.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
V. Hachinski
Shifts in Thinking About Dementia
JAMA, November 12, 2008; 300(18): 2172 - 2173.
[Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
T.J. Huynh, B. Murphy, J.A. Pettersen, H. Tu, D.J. Sahlas, L. Zhang, S.P. Symons, S. Black, T.-Y. Lee, and R.I. Aviv
CT Perfusion Quantification of Small-Vessel Ischemic Severity
AJNR Am. J. Neuroradiol., November 1, 2008; 29(10): 1831 - 1836.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
K. Rockwood and G. Gubitz
Silent Cerebral Infarction: Are We Listening?
Stroke, November 1, 2008; 39(11): 2919 - 2920.
[Full Text] [PDF]


Home page
StrokeHome page
I. Alafuzoff
Cerebral Amyloid Angiopathy, Hemorrhages and Superficial Siderosis
Stroke, October 1, 2008; 39(10): 2699 - 2700.
[Full Text] [PDF]


Home page
StrokeHome page
V. Hachinski
World Stroke Day 2008: "Little Strokes, Big Trouble"
Stroke, September 1, 2008; 39(9): 2407 - 2408.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. M. Troen, M. Shea-Budgell, B. Shukitt-Hale, D. E. Smith, J. Selhub, and I. H. Rosenberg
B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice
PNAS, August 26, 2008; 105(34): 12474 - 12479.
[Abstract] [Full Text] [PDF]


Home page
Neurorehabil Neural RepairHome page
N. J. Donovan, D. L. Kendall, S. C. Heaton, S. Kwon, C. A. Velozo, and P. W. Duncan
Conceptualizing Functional Cognition in Stroke
Neurorehabil Neural Repair, April 1, 2008; 22(2): 122 - 135.
[Abstract] [PDF]


Home page
StrokeHome page
N. Levy-Cooperman, J. Ramirez, N. J. Lobaugh, and S. E. Black
Misclassified Tissue Volumes in Alzheimer Disease Patients With White Matter Hyperintensities: Importance of Lesion Segmentation Procedures for Volumetric Analysis
Stroke, April 1, 2008; 39(4): 1134 - 1141.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. B. Wright, J. R. Festa, M. C. Paik, A. Schmiedigen, T. R. Brown, M. Yoshita, C. DeCarli, R. Sacco, and Y. Stern
White Matter Hyperintensities and Subclinical Infarction: Associations With Psychomotor Speed and Cognitive Flexibility
Stroke, March 1, 2008; 39(3): 800 - 805.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. H. Swartz, D. T. Stuss, F. Gao, and S. E. Black
Independent Cognitive Effects of Atrophy and Diffuse Subcortical and Thalamico-Cortical Cerebrovascular Disease in Dementia
Stroke, March 1, 2008; 39(3): 822 - 830.
[Abstract] [Full Text] [PDF]


Home page
J Geriatr Psychiatry NeurolHome page
J. A. Levy and G. J. Chelune
Cognitive-Behavioral Profiles of Neurodegenerative Dementias: Beyond Alzheimer's Disease
J Geriatr Psychiatry Neurol, December 1, 2007; 20(4): 227 - 238.
[Abstract] [PDF]


Home page
StrokeHome page
A. M. Hakim
Vascular Disease: The Tsunami of Health Care
Stroke, December 1, 2007; 38(12): 3296 - 3301.
[Abstract] [Full Text] [PDF]


Home page
Br Med BullHome page
J. V. Bowler
Modern concept of vascular cognitive impairment
Br. Med. Bull., September 1, 2007; 83(1): 291 - 305.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Schmidt, K. Petrovic, S. Ropele, C. Enzinger, and F. Fazekas
Progression of Leukoaraiosis and Cognition
Stroke, September 1, 2007; 38(9): 2619 - 2625.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
R. N. Kalaria
Rounding up the usual suspects: Lacunar infarction and impairment in CADASIL
Neurology, July 10, 2007; 69(2): 131 - 132.
[Full Text] [PDF]


Home page
StrokeHome page
L. H. Kuller
So, What's New?
Stroke, May 1, 2007; 38(5): 1427 - 1429.
[Full Text] [PDF]


Home page
StrokeHome page
V. Hachinski
Stroke and Vascular Cognitive Impairment: A Transdisciplinary, Translational and Transactional Approach
Stroke, April 1, 2007; 38(4): 1396 - 1396.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
J. V. Bowler and P. B. Gorelick
Advances in Vascular Cognitive Impairment 2006
Stroke, February 1, 2007; 38(2): 241 - 244.
[Full Text] [PDF]


Home page
StrokeHome page
M. Fisher, D. F. Hanley, G. Howard, E. C. Jauch, S. Warach, and for the STAIR Group
Recommendations From the STAIR V Meeting on Acute Stroke Trials, Technology and Outcomes
Stroke, February 1, 2007; 38(2): 245 - 248.
[Full Text] [PDF]


Home page
StrokeHome page
J. M. Ferro
Welcome Harmonizations
Stroke, September 1, 2006; 37(9): 2197 - 2197.
[Full Text] [PDF]